RENITRA JACKSON: Open Payments
NPI 1144399270 · HAZELWOOD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$856 in 46 payments from 15 companies in 2025. Trend: 2023 $176 · 2024 $66 · 2025 $856
Food & beverage: $856
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $210 |
| Novo Nordisk Inc | 9 | $155 |
| Amgen Inc. | 5 | $112 |
| Lilly USA, LLC | 5 | $97 |
| Abbott Laboratories | 3 | $61 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: UBRELVY, MOUNJARO, Wegovy, FREESTYLE LIBRE 3, QULIPTA, Ozempic, OTEZLA, EVENITY.
Industry payments across MO — which companies pay providers there.
